Haemodynamic definitions and updated clinical classification of pulmonary hypertension
Open accessThe DOI matches its Crossref record; 86 of the 87 references it cites were found in a registry or an index.
Abstract
Since the 1st World Symposium on Pulmonary Hypertension (WSPH) in 1973, pulmonary hypertension (PH) has been arbitrarily defined as mean pulmonary arterial pressure (mPAP) ≥25 mmHg at rest, measured by right heart catheterisation. Recent data from normal subjects has shown that normal mPAP was 14.0±3.3 mmHg. Two standard deviations above this mean value would suggest mPAP >20 mmHg as above the upper limit of normal (above the 97.5th percentile). This definition is no longer arbitrary, but based on a scientific approach. However, this abnormal elevation of mPAP is not sufficient to define pulmonary vascular disease as it can be due to an increase in cardiac output or pulmonary arterial wedge pressure. Thus, this 6th WSPH Task Force proposes to include pulmonary vascular resistance ≥3 Wood Units in the definition of all forms of pre-capillary PH associated with mPAP >20 mmHg. Prospective trials are required to determine whether this PH population might benefit from specific management. Regarding clinical classification, the main Task Force changes were the inclusion in group 1 of a subgroup “pulmonary arterial hypertension (PAH) long-term responders to calcium channel blockers”, due to the specific prognostic and management of these patients, and a subgroup “PAH with overt features of venous/capillaries (pulmonary veno-occlusive disease/pulmonary capillary haemangiomatosis) involvement”, due to evidence suggesting a continuum between arterial, capillary and vein involvement in PAH.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![FIGURE 1 The slope of the mean pulmonary arterial pressure (mPAP)–cardiac output (CO) relationship is different in normal control versus pulmonary arterial hypertension (PAH) subjects. Reproduced and modified from [26] with permission.](https://figures.cochat.ai/paper-figures/36e057af8c4544adb1c352faf9a06761/haemodynamic-definitions-and-updated-clinical-classification-of-pulmonary-figure-1.jpg)
![FIGURE 2 Knowledge of the mean pulmonary arterial pressure (mPAP)–cardiac output (CO) relationship does not allow distinction between left heart disease (LHD) and pulmonary vascular disease (PVD) patients; knowledge of exercise pulmonary arterial wedge pressure is also required. TPR: total pulmonary resistance; WU: Wood Units. Reproduced from [29] with permission.](https://figures.cochat.ai/paper-figures/8474dfd09d604465902cbdde1d1fd85a/haemodynamic-definitions-and-updated-clinical-classification-of-pulmonary-figure-2.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In the World Symposium of Pulmonary Hypertension classification of PAH, group 1 is the most common indication.”
From Indications for Lung Transplantation and Patient Selection (2022) · cites this paper as [62]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Group 2, with decreased left ventricular function, is not an indication for transplantation”
From Indications for Lung Transplantation and Patient Selection (2022) · cites this paper as [62]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Pulmonary hypertension can also occur in the context of congenital heart disease.(301)”
From Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation. (2021) · cites this paper as [301]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“group 3 with PAH and accompanying pathological changes in the lung parenchyma can be considered for transplantation.”
From Indications for Lung Transplantation and Patient Selection (2022) · cites this paper as [62]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“The current consensus is based on 2 tools for referral and listing: the REVEAL Registry 2.2 (Registry to Evaluate Early and Long-term Pulmonary Arterial Hypertension Disease Management 2.0) and 2015 European Society of Cardiology/European Respiratory Society.”
From Indications for Lung Transplantation and Patient Selection (2022) · cites this paper as [62]
Experimental — accuracy not yet measured
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
Galiè, N., Humbert, M., Vachiery, J.-L., Gibbs, S., Lang, I., Torbicki, A., Simonneau, G., Peacock, A., Vonk Noordegraaf, A., Beghetti, M., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv317 · Cited by 6,931
Self-citationDe Rosa, S., Samoni, S., Villa, G., & Ronco, C. (2017) · Blood Purification · doi:10.1159/000452650 · Cited by 5,007
Updated clinical classification of pulmonary hypertension
Simonneau, G., Gatzoulis, M. A., Adatia, I., Celermajer, D., Denton, C., Ghofrani, A., Gomez Sanchez, M. A., Krishna Kumar, R., Landzberg, M., Machado, R. F., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.029 · Cited by 4,191
Self-citationGaliè, N., Humbert, M., Vachiery, J.-L., Gibbs, S., Lang, I., Torbicki, A., Simonneau, G., Peacock, A., Vonk Noordegraaf, A., Beghetti, M., et al. (2015) · European Respiratory Journal · doi:10.1183/13993003.01032-2015 · Cited by 3,172
Self-citationUpdated Clinical Classification of Pulmonary Hypertension
Simonneau, G., Robbins, I. M., Beghetti, M., Channick, R. N., Delcroix, M., Denton, C. P., Elliott, C. G., Gaine, S. P., Gladwin, M. T., Jing, Z.-C., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.04.012 · Cited by 2,093
Self-citationClinical classification of pulmonary hypertension
Simonneau, G., Galiè, N., Rubin, L. J., Langleben, D., Seeger, W., Domenighetti, G., Gibbs, S., Lebrec, D., Speich, R., Beghetti, M., et al. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.02.037 · Cited by 1,897
Self-citationDefinitions and Diagnosis of Pulmonary Hypertension
Hoeper, M. M., Bogaard, H. J., Condliffe, R., Frantz, R., Khanna, D., Kurzyna, M., Langleben, D., Manes, A., Satoh, T., Torres, F., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.032 · Cited by 1,766
The Effect of High Doses of Calcium-Channel Blockers on Survival in Primary Pulmonary Hypertension
Rich, S., Kaufmann, E., & Levy, P. S. (1992) · New England Journal of Medicine · doi:10.1056/nejm199207093270203 · Cited by 1,550
Pulmonary Hypertension as a Risk Factor for Death in Patients with Sickle Cell Disease
Gladwin, M. T., Sachdev, V., Jison, M. L., Shizukuda, Y., Plehn, J. F., Minter, K., Brown, B., Coles, W. A., Nichols, J. S., Ernst, I., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa035477 · Cited by 1,325
Guidelines for the diagnosis and treatment of pulmonary hypertension
(2009) · European Respiratory Journal · doi:10.1183/09031936.00139009 · Cited by 1,300
Self-citation
Research works printed but not linked: 2
- Reeves J , Dempsey J , Grover R . Pulmonary circulation during exercise. In: Weir EK , Reeves JT , eds. Pulmonary Vascular Physiology and Physiopathology. New York, Marcel Dekker, 1989; pp. 107–133. · doi:10.1201/9781003573739-5
- Tamura Y , Furukawa A , Li T , et al. Severe pulmonary arterial hypertension in patients treated by Chinese herb nature indigo: Qing-Dai. Poster presentation at the 6th World Symposium on Pulmonary Hypertension, Nice, 2018; A108.
Cited by
Items 901–1,000 of 1,004
Israël‐Biet, D., Bernardinello, N., Pastré, J., Tana, C., & Spagnolo, P. (2024) · Diagnostics · doi:10.3390/diagnostics14040395 · Cited by 20
Erdoğan, M., Avcı, B. K., Ebren, C., Ersoy, Y., Öngen, Z., Öngen, G., Hamuryudan, V., & Hatemi, G. (2023) · Clinical and Experimental Rheumatology · doi:10.55563/clinexprheumatol/gzo4r2 · Cited by 20
Zhao, W., Huang, Z., Diao, X., Yang, Z., Zhao, Z., Xia, Y. F., Zhao, Q., Sun, Z., Xi, Q., Huo, Y., et al. (2025) · npj Digital Medicine · doi:10.1038/s41746-025-01593-3 · Cited by 20
Rosenkranz, S., Diller, G., Dumitrescu, D., Ewert, R., Ghofrani, H. A., Grünig, E., Halank, M., Held, M., Kaemmerer, H. M., Klose, H. F. E., et al. (2019) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/a-0918-3772 · Cited by 20
Pulmonary hypertension in HFpEF and HFrEF: Pathophysiology, diagnosis, treatment approaches
Rosenkranz, S., Kramer, T., Gerhardt, F., Opitz, C. F., Olsson, K. M., & Hoeper, M. M. (2019) · Herz · doi:10.1007/s00059-019-4831-6 · Cited by 20
Sanders, J. L., Han, Y., Urbina, M. F., Systrom, D. M., & Waxman, A. B. (2019) · Pulmonary Circulation · doi:10.1177/2045894019882623 · Cited by 20
Hypochloremia Is a Noninvasive Predictor of Mortality in Pulmonary Arterial Hypertension
Prins, K. W., Kalra, R., Rose, L., Assad, T. R., Archer, S. L., Bajaj, N. S., Weir, Ε. K., Prisco, S. Z., PRITZKER, M. R., Lutsey, P. L., et al. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.119.015221 · Cited by 20
Liver disease and heart failure
Correale, M., Tricarico, L., Leopizzi, A., Mallardi, A., Mazzeo, P., Tucci, S., Grazioli, D., Biase, M. D., & Brunetti, N. D. (2020) · Panminerva Medica · doi:10.23736/s0031-0808.19.03768-6 · Cited by 20
Beik, A., Najafipour, H., Joukar, S., Rajabi, S., Iranpour, M., & Kordestani, Z. (2020) · Clinical and Experimental Hypertension · doi:10.1080/10641963.2020.1860080 · Cited by 20
Prevalence and clinical association with calcinosis cutis in early systemic sclerosis
Muktabhant, C., Thammaroj, P., Chowchuen, P., & Foocharoen, C. (2021) · Modern Rheumatology · doi:10.1080/14397595.2021.1886654 · Cited by 20
Lin, X., Yang, Y., Sun, B., Liu, B., Zeng, Q., & Xiong, C. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.120.018374 · Cited by 20
Guía ESC 2020 para el tratamiento de las cardiopatías congénitas del adulto
Baumgartner, H., Backer, J. F. A. D., Babu‐Narayan, S. V., Budts, W., Chessa, M., Diller, G., Iung, B., Kluin, J., Lang, I. M., Meijboom, F. J., et al. (2021) · Revista Española de Cardiología · doi:10.1016/j.recesp.2020.10.023 · Cited by 20
Self-citationTea, I., & Hussain, I. (2021) · Methodist DeBakey Cardiovascular Journal · doi:10.14797/afui4711 · Cited by 20
Mouse model of experimental pulmonary hypertension: Lung angiogram and right heart catheterization
Xiong, M., Jain, P., Chen, J., Babicheva, A., Zhao, T., Alotaibi, M., Kim, N. H., Lai, N., Izadi, A., Rodriguez, M., et al. (2021) · Pulmonary Circulation · doi:10.1177/20458940211041512 · Cited by 20
Prognostic impact of hypochromic erythrocytes in patients with pulmonary arterial hypertension
Xanthouli, P., Theobald, V., Benjamin, N., Marra, A. M., D'Agostino, A. G., Egenlauf, B., Shaukat, M., Ding, C., Cittadini, A., Bossone, E., et al. (2021) · Respiratory Research · doi:10.1186/s12931-021-01884-9 · Cited by 20
Mamazhakypov, A., Hein, L., & Lother, A. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107987 · Cited by 20
The definition of pulmonary hypertension: history, practical implications and current controversies
Kovács, G., & Olschewski, H. (2021) · Breathe · doi:10.1183/20734735.0076-2021 · Cited by 20
Pulmonary hypertension in pregnancy-the Anesthesiologist's perspective
McNeil, A., Chen, J., & Meng, M. (2021) · International Journal of Cardiology Congenital Heart Disease · doi:10.1016/j.ijcchd.2021.100234 · Cited by 20
An Overview of miRNAs Involved in PASMC Phenotypic Switching in Pulmonary Hypertension
Zhang, W., Tao, Z., Xu, F., Diao, Q., Li, J., Zhou, L., Miao, Y., Xie, S., Wan, J., & Xu, R. (2021) · BioMed Research International · doi:10.1155/2021/5765029 · Cited by 20
Deng, J. (2021) · Journal of Cardiothoracic Surgery · doi:10.1186/s13019-021-01696-4 · Cited by 20
Pulmonary Hypertension in Adults with Congenital Heart Disease
Goldstein, S. A., & Krasuski, R. A. (2021) · Cardiology Clinics · doi:10.1016/j.ccl.2021.08.006 · Cited by 20
Stem Cell and Exosome Therapy in Pulmonary Hypertension
Oh, S., Jung, J., Ahn, K. J., Jang, A. Y., Byun, K., Yang, P. C.-M., & Chung, W. (2022) · Korean Circulation Journal · doi:10.4070/kcj.2021.0191 · Cited by 20
Nies, M., Yang, J., Griffiths, M., Damico, R. L., Zhu, J., Vaydia, D., Fu, Z., Brandal, S., Austin, E. D., Ivy, D. D., et al. (2022) · Pulmonary Circulation · doi:10.1002/pul2.12039 · Cited by 20
The Impact of Sex Chromosomes in the Sexual Dimorphism of Pulmonary Arterial Hypertension
Predescu, D. N., Mokhlesi, B., & Predescu, S. A. (2022) · American Journal Of Pathology · doi:10.1016/j.ajpath.2022.01.005 · Cited by 20
Zhou, J., Chou, O. H. I., Wong, K. H. G., Lee, S., Leung, K. S. K., Liu, T., Cheung, B. M. Y., Wong, I. C. K., Tse, G., & Zhang, Q. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.735906 · Cited by 20
Role of the electrocardiogram in the risk stratification of pulmonary hypertension
Hendriks, P. M., Kauling, R. M., Geenen, L. W., Eindhoven, J. A., Roos‐Hesselink, J. W., Boomars, K. A., & van den Bosch, A. E. (2022) · Heart · doi:10.1136/heartjnl-2022-321475 · Cited by 20
Balloon Pulmonary Angioplasty in the Management of Chronic Thromboembolic Pulmonary Hypertension
Higuchi, S., Horinouchi, H., Aoki, T., Nishii, T., Ota, Y., Ueda, J., Tsuji, A., Ota, H., Ogo, T., & Fukuda, T. (2022) · Radiographics · doi:10.1148/rg.210102 · Cited by 20
Xu, J., Liang, C., & Li, J. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.1078200 · Cited by 20
Nathan, S. D., Fernandes, P., Psotka, M. A., Vitulo, P., Piccari, L., Antoniou, K., Nikkho, S. M., & Stockbridge, N. (2022) · Pulmonary Circulation · doi:10.1002/pul2.12178 · Cited by 20
Wood, K. C., Durgin, B. G., Schmidt, H. M., Hahn, S. A., Baust, J., Bachman, T. N., Vitturi, D. A., Ghosh, S., Ofori-Acquah, S. F., Mora, A. L., et al. (2019) · Blood Advances · doi:10.1182/bloodadvances.2019000621 · Cited by 20
Stevens, H., Fang, W., Clements, W., Bloom, J. E., McFadyen, J. D., & Tran, H. A. (2020) · TH Open · doi:10.1055/s-0040-1708558 · Cited by 20
Pulmonary Hypertension in Heart Failure Patients
RAO, S. D., Adusumalli, S., & Mazurek, J. A. (2020) · Cardiac failure review · doi:10.15420/cfr.2019.09 · Cited by 20
Male same-sex intimate partner violence : a descriptive review and call for further research
Jeffries, S., & Ball, M. J. (2008) · QUT ePrints (Queensland University of Technology) · Cited by 20
Complications in Idiopathic Pulmonary Fibrosis: Focus on Their Clinical and Radiological Features
Galioto, F., Palmucci, S., Astuti, G. M., Vancheri, A., Distefano, G., Tiralongo, F., Libra, A., Cusumano, G., Basile, A., & Vancheri, C. (2020) · Diagnostics · doi:10.3390/diagnostics10070450 · Cited by 20
Central Role of Dendritic Cells in Pulmonary Arterial Hypertension in Human and Mice
van Uden, D., Koudstaal, T., van Hulst, J. A. C., Bergen, I. M., Gootjes, C., Morrell, N. W., Loo, G., von der Thüsen, J. H., van den Bosch, T. P. P., Ghigna, M., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041756 · Cited by 20
Self-citationMcGregor, P., Boosalis, V. A., & Aragam, J. R. (2021) · SAGE Open Medical Case Reports · doi:10.1177/2050313x21994031 · Cited by 20
Zeng, Y., Li, N., Zheng, Z., Chen, R., Liu, W., Cheng, J., Zhu, J., Zeng, M., Peng, M., & Hong, C. (2021) · Bioengineered · doi:10.1080/21655979.2021.1936816 · Cited by 20
Lang, I. M., & Matsubara, H. (2019) · European Respiratory Journal · doi:10.1183/13993003.00843-2019 · Cited by 20
Peripheral Blood T Cells of Patients with IPAH Have a Reduced Cytokine-Producing Capacity
van Uden, D., Koudstaal, T., van Hulst, J. A. C., Vink, M., van Nimwegen, M., van den Toorn, L. M., Chandoesing, P. P., van den Bosch, A. E., Kool, M., Hendriks, R. W., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23126508 · Cited by 19
Haddad, F., Cauwenberghs, N., Daubert, M. A., Kobayashi, Y., Bloomfield, G. S., Fleischmann, D., Koweek, L., Maron, D. J., Rodríguez, F., Liao, Y. J., et al. (2022) · Journal of cardiovascular computed tomography · doi:10.1016/j.jcct.2022.06.003 · Cited by 19
Sinha, M., Zabini, D., Guntur, D., Nagaraj, C., Enyedi, P., Olschewski, H., Kuebler, W. M., & Olschewski, A. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108249 · Cited by 19
Hemodynamic indices in pulmonary hypertension: a narrative review
Manek, G., Gupta, M., Chhabria, M., Bajaj, D., Agrawal, A., & Tonelli, A. R. (2022) · Cardiovascular Diagnosis and Therapy · doi:10.21037/cdt-22-244 · Cited by 19
Right Heart Function in Cardiorenal Syndrome
Kramer, T., Brinkkoetter, P. T., & Rosenkranz, S. (2022) · Current Heart Failure Reports · doi:10.1007/s11897-022-00574-x · Cited by 19
Diagnosis and management of pulmonary arterial hypertension
Cullivan, S., Higgins, M., & Gaine, S. (2022) · Breathe · doi:10.1183/20734735.0168-2022 · Cited by 19
Simpson, C. E., Hemnes, A. R., Griffiths, M., Grünig, G., Tang, W. H. W., Garcia, J. G. N., Barnard, J., COMHAIR, S. A. A., Damico, R. L., Mathai, S. C., et al. (2023) · Arthritis & Rheumatology · doi:10.1002/art.42632 · Cited by 19
Echocardiography Imaging of the Right Ventricle: Focus on Three-Dimensional Echocardiography
Molnár, A., Sánta, A., & Merkely, B. P. (2023) · Diagnostics · doi:10.3390/diagnostics13152470 · Cited by 19
Rischard, F. P., Bernardo, R. J., Vanderpool, R. R., Kwon, D. H., Acharya, T., Park, M. M., Katrynuik, A., Insel, M. B., Kubba, S., Badagliacca, R., et al. (2023) · Circulation Heart Failure · doi:10.1161/circheartfailure.123.010555 · Cited by 19
Torres, G., Lancaster, A. C., Yang, J., Griffiths, M., Brandal, S., Damico, R. L., Vaidya, D. M., Simpson, C. E., Martin, L. J., Pauciulo, M. W., et al. (2023) · Pulmonary Circulation · doi:10.1002/pul2.12284 · Cited by 19
Tyvaso DPI: Drug-device characteristics and patient clinical considerations
McEvoy, C. A., Argula, R. G., Sahay, S., Shapiro, S., Eagan, C., Hickey, A. J., Smutney, C., Dillon, C., Winkler, T., Davis, B. N. J., et al. (2023) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2023.102266 · Cited by 19
Long Noncoding RNA MALAT1: Salt-Sensitive Hypertension
Khan, M. M., & Kirabo, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25105507 · Cited by 19
Smith, H. D., Thompson, A. A. R., Akil, M., Alabed, S., Charalampopoulos, A. F., Dwivedi, K., Elliot, C. A., Hameed, A. G., Haque, A., Hamilton, N., et al. (2024) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2024.06.007 · Cited by 19
Bosentan for Treatment of Pediatric Idiopathic Pulmonary Arterial Hypertension: State-of-the-Art
Wang, Y., Chen, S. Y., & Du, J. (2019) · Frontiers in Pediatrics · doi:10.3389/fped.2019.00302 · Cited by 19
Kido, K., & Coons, J. C. (2019) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2314 · Cited by 19
Argula, R. G., Ward, C., & Feghali‐Bostwick, C. A. (2019) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s219024 · Cited by 19
Wiedenroth, C. B., Rieth, A. J., Kriechbaum, S. D., Ghofrani, H. A., Breithecker, A., Haas, M., Roller, F. C., Richter, M. J., Lankeit, M., Mielzarek, L., et al. (2020) · Pulmonary Circulation · doi:10.1177/2045894020917884 · Cited by 19
Sex Differences in Portopulmonary Hypertension
DuBrock, H. M., Cartin‐Ceba, R., Channick, R. N., Kawut, S. M., & Krowka, M. J. (2020) · CHEST Journal · doi:10.1016/j.chest.2020.07.081 · Cited by 19
Self-citationPulmonary hypertension associated with left-sided heart failure
Adler, J., Gerhardt, F., Wißmüller, M., Adler, C., Baldus, S. E., & Rosenkranz, S. (2020) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000791 · Cited by 19
Liu, S., Wang, Y., Lu, S., Hu, J. R., Zeng, X., Liu, W., Wang, Y., & Wang, Z. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118877 · Cited by 19
Mumby, S. E., Perros, F., Hui, C., Xu, B., Xu, W., Elyasigomari, V., Hautefort, A., Manaud, G., Humbert, M. J. C., Chung, K. F., et al. (2021) · Pulmonary Circulation · doi:10.1177/2045894021996190 · Cited by 19
Pulmonary Hypertension Complicating Pregnancy
Krishnan, S., Fricke, E. M., Cordoba, M. I., Chalifoux, L. A., & Girgis, R. E. (2021) · Current Pulmonology Reports · doi:10.1007/s13665-021-00275-1 · Cited by 19
Pulmonary Hypertension in Heart Failure
Jang, A. Y., Park, S. J., & Chung, W. (2021) · International Journal of Heart Failure · doi:10.36628/ijhf.2020.0053 · Cited by 19
Perioperative Management of Pulmonary Hypertension. A Review
Wood, C., Balčiūnas, M., Lordan, J. L., & Mellor, A. J. (2021) · The Journal of Critical Care Medicine · doi:10.2478/jccm-2021-0007 · Cited by 19
Montané, B., Fiore, A. M., Reznicek, E., Jain, V., Jellis, C. L., Rokadia, H. K., Li, M., Wang, X., Dweik, R. A., Loh, E., et al. (2021) · CHEST Journal · doi:10.1016/j.chest.2021.06.046 · Cited by 19
An, Q.-Y., Wang, L., Yuan, P., Zhao, Q., Gong, S., Zhang, R., He, J., Luo, C., Qiu, H., Li, H., et al. (2021) · Annals of Palliative Medicine · doi:10.21037/apm-21-1758 · Cited by 19
NEF, H. M., Achenbach, S. S., Birkemeyer, R., Bufe, A., Dörr, O., Elsässer, A., Gaede, L., Gori, T., Hoffmeister, H. M., Hofmann, F. J., et al. (2021) · Der Kardiologe · doi:10.1007/s12181-021-00493-6 · Cited by 19
Buehler, P. W., Swindle, D. C., Pak, D. I., Fini, M. A., Hassell, K. L., Nuss, R., Wilkerson, R. B., D’Alessandro, A., & Irwin, D. C. (2021) · Pulmonary Circulation · doi:10.1177/20458940211055996 · Cited by 19
Kolaitis, N. A., Lammi, M., Mazimba, S., Feldman, J., McConnell, W., Sager, J. S., Raval, A. A., Simon, M. A., & Marco, T. D. (2022) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202111-2481le · Cited by 19
Cytokine profiling in pulmonary arterial hypertension: the role of redox homeostasis and sex
Rafikov, R., Rischard, F. P., Vasilyev, M., Varghese, M. V., Yuan, J. X. ‐., Desai, A. A., Garcia, J. G. N., & Rafikova, O. (2022) · Translational research · doi:10.1016/j.trsl.2022.03.013 · Cited by 19
Xiao, F., Zhang, R., & Wang, L. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.913904 · Cited by 19
Hemodynamic Responses to Provocative Maneuvers during Right Heart Catheterization
Montané, B., Tonelli, A. R., Arunachalam, A., Bhattacharyya, A., Li, M., Wang, X., & Chaisson, N. F. (2022) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202201-077oc · Cited by 19
Exercise Rehabilitation Training in Patients With Pulmonary Hypertension: A Review
Dong, C., & Li, Y. (2022) · Heart Lung and Circulation · doi:10.1016/j.hlc.2022.06.660 · Cited by 19
Emerging phenotypes of pulmonary hypertension associated with COPD: a field guide
García, A. R., & Piccari, L. (2022) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000890 · Cited by 19
Salt-inducible kinases: new players in pulmonary arterial hypertension?
António, T., Soares-da-Silva, P., Pires, N. M., & Gomes, P. (2022) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2022.06.008 · Cited by 19
Kane, C. J., Salama, A. A., Pislaru, C., Kane, G. C., Pislaru, S. V., & Lin, G. (2022) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2022.09.003 · Cited by 19
Qin, J., Wang, G., & Han, D. H. (2022) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2022.101466 · Cited by 19
Feline pulmonary hypertension: are we overlooking an important comorbidity?
Rolph, K. E., & Cavanaugh, S. M. (2022) · Journal of Feline Medicine and Surgery · doi:10.1177/1098612x221127233 · Cited by 19
Torres-Rojas, M.-B., Cueto‐Robledo, G., Roldán-Valadéz, E., Navarro-Vergara, D.-I., García‐Cesar, M., Graniel-Palafox, L.-E., & Serrano‐Loyola, R. (2023) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2023.101645 · Cited by 19
Chen, W., Luo, J., Chen, J., Chen, Y., Li, Z., Qiu, H., & Li, J. (2023) · BMC Pulmonary Medicine · doi:10.1186/s12890-023-02355-1 · Cited by 19
Shi, H., Chen, L., Zhang, S., Li, R., Wu, Y., Zou, H., Wang, C., Cai, M., & Lin, H. (2023) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2023.115126 · Cited by 19
Takagi, K., Kawamoto, M., Higuchi, T., Tochimoto, A., Harigai, M., & Kawaguchi, Y. (2020) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.13822 · Cited by 19
Nutraceuticals in the Treatment of Pulmonary Arterial Hypertension
Sánchez-Gloria, J. L., Osorio‐Alonso, H., Arellano-Buendía, A. S., Carbó, R., Hernández-Díazcouder, A., Guzmán-Martín, C. A., Rubio‐Gayosso, I., & Sánchez‐Muñoz, F. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21144827 · Cited by 19
Use of Anticoagulants in Patients with Pulmonary Hypertension
Bertoletti, L., Mismetti, V., & Giannakoulas, G. A. (2020) · Hämostaseologie · doi:10.1055/a-1171-3995 · Cited by 19
Niclosamide attenuates lung vascular remodeling in experimental pulmonary arterial hypertension
Braga, C. L., Felix, N. S., Teixeira¹, D. E., Vieira, J. B., Silva-Aguiar, R. P., Bose, R. M., Antunes, M. A., Rocha, N. N., Caruso‐Neves, C., Cruz, F. F., et al. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173438 · Cited by 19
Jang, A. Y., Kim, B.-G., Kwon, S., Seo, J.-Y., Kim, H., Chang, H., Chang, S., Cho, G., Rhee, S. J., Jung, H. O., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0238698 · Cited by 19
Yu, W., Xu, G., Chen, H., Xiao, L., Liu, G., Hu, P., Li, S., Kasim, V., Zeng, C., & Tong, X. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.12.025 · Cited by 18
Ma, R., Cheng, L., Song, Y., Sun, Y., Gui, W., Deng, Y. L., Xie, C., & Liu, M. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.940784 · Cited by 18
Pulmonary hypertension due to high cardiac output
Qaiser, K. N., Sahay, S., & Tonelli, A. R. (2022) · Respiratory Medicine · doi:10.1016/j.rmed.2022.107034 · Cited by 18
Risk stratification in adult and pediatric pulmonary arterial hypertension: A systematic review
Lokhorst, C., van der Werf, S., Berger, R. M. F., & Douwes, J. M. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.1035453 · Cited by 18
Oxygen Targets in Neonatal Pulmonary Hypertension
Lakshminrusimha, S., & Abman, S. H. (2023) · Clinics in Perinatology · doi:10.1016/j.clp.2023.12.003 · Cited by 18
Schulze, K. M., Weber, R. E., Horn, A. G., Hageman, K. S., Kenney, N., Behnke, B. J., Poole, D. C., & Musch, T. I. (2024) · The Journal of Physiology · doi:10.1113/jp287549 · Cited by 18
Reduction in pulmonary artery pressures with use of sacubitril/valsartan
Simone, V. D., Guarise, P., Zanotto, G., & Morando, G. (2019) · Journal of Cardiology Cases · doi:10.1016/j.jccase.2019.08.006 · Cited by 18
Pulmonary Circulation in Obesity, Diabetes, and Metabolic Syndrome
Khaing, P., Pandit, P., Awsare, B. K., & Summer, R. S. (2019) · Comprehensive physiology · doi:10.1002/cphy.c190018 · Cited by 18
Vaidya, A., Golbus, J. R., Vedage, N. A., Mazurek, J. A., Raza, F., & Forfia, P. R. (2020) · Pulmonary Circulation · doi:10.1177/2045894020950225 · Cited by 18
Onda, T., Akimoto, T., Hayasaka, I., Ikeda, M., Furuse, Y., Ando, A., Nakamura, Y., Honjo, R., Manabe, A., Furuta, I., et al. (2021) · Early Human Development · doi:10.1016/j.earlhumdev.2021.105323 · Cited by 18
Lichtblau, M., Berlier, C., Saxer, S., Carta, A. F., Mayer, L. C., Groth, A., Bader, P. R., Schneider, S., Furian, M., Schwarz, E. I., et al. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.681473 · Cited by 18
Zaky, A., Zafar, I., Juncos, J. X. M., Husain, M., Mariappan, N., Morgan, C. J., Hamid, T., Frölich, M. A., Ahmad, S., & Ahmad, A. M. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.705666 · Cited by 18
Transcriptomic profile of cationic channels in human pulmonary arterial hypertension
Pérez‐Vizcaíno, F., Cogolludo, A. L., & Mondéjar‐Parreño, G. (2021) · Scientific Reports · doi:10.1038/s41598-021-95196-z · Cited by 18
Munshi, R., Pellegrini, J. R., Patel, P., Kashin, M., Kang, J., Sexton, R., Russe-Russe, J. R., Makaryus, A. N., Patel, P., Thakkar, S. J., et al. (2021) · Pulmonary Circulation · doi:10.1177/20458940211046838 · Cited by 18
Lower Plasma Melatonin Levels Predict Worse Long-Term Survival in Pulmonary Arterial Hypertension
Cai, Z., Klein, T., Geenen, L. W., Tu, L., Tian, S., van den Bosch, A. E., de Rijke, Y. B., Reiss, I. K. M., Boersma, E., Duncker, D. J., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9051248 · Cited by 17
“Pulmonary hypertension (PH) is a severe disease with a wide spectrum of underlying etiologies [1].”
BackgroundRex, S., & Devroe, S. (2022) · Best Practice & Research Clinical Anaesthesiology · doi:10.1016/j.bpa.2022.02.005 · Cited by 16
Metadata
- Authors
- Simonneau, G., Montani, D., Celermajer, D. S., Denton, C. P., Gatzoulis, M. A., Krowka, M., Williams, P. G., & Souza, R.
- Affiliations
- Université Paris-Sud (FR)
- The University of Sydney (AU)
- The Royal Free Hospital (GB)
- Mayo Clinic (US)
- Milpark Hospital (ZA)
- ORCID
- Venue
- European Respiratory Journal
- Publisher
- European Respiratory Society (ERS)
- Published
- 2019-01
- Volume
- 53
- Issue
- 1
- Pages
- 1801913
- ISSN
- 0903-1936 (ISSN-L)
- 1399-3003
- PMC
- PMC6351336
- OpenAlex
- W2904180601
- Cited by
- 3,813
- References
- 87
- Citations by year
- 2026: 208 · 2025: 356 · 2024: 480 · 2023: 541 · 2022: 716 · 2021: 711 · 2020: 558 · 2019: 225
- FWCI
- 282.13
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- European Respiratory Journal (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- Agence Nationale de la Recherche (ANR-10-LABX-0033)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
- Health Sciences › Medicine › Genetics (clinical) › Vascular Anomalies and Treatments
- Health Sciences › Medicine › Surgery › Hemodynamic Monitoring and Therapy
- Keywords
- pulmonary hypertension, clinical classification, precapillary pulmonary hypertension, pulmonary arterial hypertension, pulmonary vascular resistance, mean pulmonary artery pressure, pulmonary vascular disease, pulmonary veno-occlusive disease, calcium channel blockers, right heart catheterization, reference values
- MeSH terms
- Consensus Statements as Topic, Heart Diseases, Hemodynamics, Humans, Hypertension, Pulmonary
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.